Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xiong Xia

Showing results (41-50 of 72) with videos related to

Pageof 8
Sort By:
JAMA Network Open|September 23, 2021
Assessment of Survival Model Performance Following Inclusion of Epstein-Barr Virus DNA Status in Conventional TNM Staging Groups in Epstein-Barr Virus-Related Nasopharyngeal CarcinomaWang-Zhong Li, Hai-Jun Wu, Shu-Hui Lv, et al.
BMC Cancer|May 6, 2023
Tumor residue in patients with stage II-IVA nasopharyngeal carcinoma who received intensity-modulated radiation therapy: development and validation of a prediction nomogram integrating postradiotherapy plasma Epstein-Barr virus deoxyribonucleic acid, clinical stage, and radiotherapy doseYing-Ying Huang, Jia-Yu Zhou, Ze-Jiang Zhan, et al.
International Journal of Radiation Oncology, Biology, Physics|August 28, 2020
Development of a Prognostic Model to Identify the Suitable Definitive Radiation Therapy Candidates in de Novo Metastatic Nasopharyngeal Carcinoma: A Real-World StudyWang-Zhong Li, Shu-Hui Lv, Guo-Ying Liu, et al.
Cancer Medicine|December 14, 2019
Prognostic value of early radiological response to first-line platinum-containing chemotherapy in patients with metastatic nasopharyngeal carcinomaGuo-Ying Liu, Wang-Zhong Li, Kang-Qiang Peng, et al.
Oral Oncology|March 30, 2017
Combining cetuximab with chemoradiotherapy in patients with locally advanced nasopharyngeal carcinoma: A propensity score analysisWei-Xiong Xia, Hu Liang, Xing Lv, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 19, 2025
Capecitabine maintenance therapy in patients with residual nasopharyngeal carcinoma: a single-arm, phase 2 trialXun Cao, Zhuo-Ying Luo, Hao-Yang Huang, et al.
Journal of Experimental & Clinical Cancer Research : CR|April 19, 2018
The CXCL5/CXCR2 axis contributes to the epithelial-mesenchymal transition of nasopharyngeal carcinoma cells by activating ERK/GSK-3β/snail signallingWen-Ze Qiu, Hai-Bo Zhang, Wei-Xiong Xia, et al.
Chinese Journal of Cancer|June 13, 2015
Elevated peripheral blood lymphocyte-to-monocyte ratio predicts a favorable prognosis in the patients with metastatic nasopharyngeal carcinomaRou Jiang, Xiu-Yu Cai, Zhong-Han Yang, et al.
Cancer Communications (London, England)|May 17, 2018
Effect of induction chemotherapy with cisplatin, fluorouracil, with or without taxane on locoregionally advanced nasopharyngeal carcinoma: a retrospective, propensity score-matched analysisGuo-Ying Liu, Xing Lv, Yi-Shan Wu, et al.
Nature Communications|January 14, 2025
Selective utilization of medicinal polysaccharides by human gut Bacteroides and Parabacteroides speciesZepeng Qu, Hongbin Liu, Ji Yang, et al.
Pageof 8

Showing results (41-50 of 72) with videos related to

Sort By:
Pageof 8
JAMA Network Open|September 23, 2021
Assessment of Survival Model Performance Following Inclusion of Epstein-Barr Virus DNA Status in Conventional TNM Staging Groups in Epstein-Barr Virus-Related Nasopharyngeal CarcinomaWang-Zhong Li, Hai-Jun Wu, Shu-Hui Lv, et al.
BMC Cancer|May 6, 2023
Tumor residue in patients with stage II-IVA nasopharyngeal carcinoma who received intensity-modulated radiation therapy: development and validation of a prediction nomogram integrating postradiotherapy plasma Epstein-Barr virus deoxyribonucleic acid, clinical stage, and radiotherapy doseYing-Ying Huang, Jia-Yu Zhou, Ze-Jiang Zhan, et al.
International Journal of Radiation Oncology, Biology, Physics|August 28, 2020
Development of a Prognostic Model to Identify the Suitable Definitive Radiation Therapy Candidates in de Novo Metastatic Nasopharyngeal Carcinoma: A Real-World StudyWang-Zhong Li, Shu-Hui Lv, Guo-Ying Liu, et al.
Cancer Medicine|December 14, 2019
Prognostic value of early radiological response to first-line platinum-containing chemotherapy in patients with metastatic nasopharyngeal carcinomaGuo-Ying Liu, Wang-Zhong Li, Kang-Qiang Peng, et al.
Oral Oncology|March 30, 2017
Combining cetuximab with chemoradiotherapy in patients with locally advanced nasopharyngeal carcinoma: A propensity score analysisWei-Xiong Xia, Hu Liang, Xing Lv, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 19, 2025
Capecitabine maintenance therapy in patients with residual nasopharyngeal carcinoma: a single-arm, phase 2 trialXun Cao, Zhuo-Ying Luo, Hao-Yang Huang, et al.
Journal of Experimental & Clinical Cancer Research : CR|April 19, 2018
The CXCL5/CXCR2 axis contributes to the epithelial-mesenchymal transition of nasopharyngeal carcinoma cells by activating ERK/GSK-3β/snail signallingWen-Ze Qiu, Hai-Bo Zhang, Wei-Xiong Xia, et al.
Chinese Journal of Cancer|June 13, 2015
Elevated peripheral blood lymphocyte-to-monocyte ratio predicts a favorable prognosis in the patients with metastatic nasopharyngeal carcinomaRou Jiang, Xiu-Yu Cai, Zhong-Han Yang, et al.
Cancer Communications (London, England)|May 17, 2018
Effect of induction chemotherapy with cisplatin, fluorouracil, with or without taxane on locoregionally advanced nasopharyngeal carcinoma: a retrospective, propensity score-matched analysisGuo-Ying Liu, Xing Lv, Yi-Shan Wu, et al.
Nature Communications|January 14, 2025
Selective utilization of medicinal polysaccharides by human gut Bacteroides and Parabacteroides speciesZepeng Qu, Hongbin Liu, Ji Yang, et al.
Pageof 8